MedPath

Betaloan SUIK

Betaloan Suik Kit

Approved
Approval ID

016a47f2-8524-4178-e063-6294a90ab36e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 26, 2023

Manufacturers
FDA

Advanced Rx Pharmacy of Tennessee, LLC

DUNS: 117023142

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Betamethasone Sodium Phosphate and Betamethasone Acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code80425-0347
Product Classification
G
Generic Name
Betamethasone Sodium Phosphate and Betamethasone Acetate
Product Specifications
Route of AdministrationINTRA-ARTICULAR, INTRAMUSCULAR, INTRALESIONAL
Effective DateJuly 26, 2023
FDA Product Classification

INGREDIENTS (7)

SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Code: 593YOG76RN
Classification: IACT
SODIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Code: 22ADO53M6F
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
BETAMETHASONE SODIUM PHOSPHATEActive
Quantity: 3 mg in 1 mL
Code: 7BK02SCL3W
Classification: ACTIM
WATERInactive
Code: 059QF0KO0R
Classification: IACT
BETAMETHASONE ACETATEActive
Quantity: 3 mg in 1 mL
Code: TI05AO53L7
Classification: ACTIB
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 7/26/2023

Principal Display Panel – Carton Label

NDC: 80425-0347-01 Rx Only

Betaloan SUIK

Kit Contains

1 Betamethasone Sodium Phosphate and Betamethasone Acetate mg/mL (5mL)

1 Gebauer's Pain Ease ®(30mL)

1 BD Integra Syringe with Retracting BD PrecisionGlide™ Needle (3mL 23G x 1”)

1 BD Integra Syringe with Retracting BD PrecisionGlide™ Needle (3mL 25G x 1”)

1 Pair Nitrile Powder Free Sterile Gloves (M)

1 Drape

1 Adhesive Bandage

1 Isopropyl Alcohol 70% Prep Pad

5 Non-sterile 4x4 gauze

1 Face Mask

1 Dose

Single Use Only

Distributed by

Advanced Rx Pharmacy of Tennessee, LLC

label 1

DESCRIPTION SECTION

LOINC: 34089-3Updated: 7/26/2023

DESCRIPTION

Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP is a sterile aqueous suspension containing betamethasone 3 mg per milliliter as betamethasone sodium phosphate, and betamethasone acetate 3 mg per milliliter. Inactive ingredients per mL: dibasic sodium phosphate 7.1 mg; monobasic sodium phosphate 3.4 mg; edetate disodium 0.1 mg; and benzalkonium chloride 0.2 mg as a preservative. The pH is adjusted to between 6.8 and 7.2.

The formula for betamethasone sodium phosphate is C 22H 28FNa 2O 8P and it has a molecular weight of 516.40. Chemically, it is 9-Fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 21-(disodium phosphate).

The formula for betamethasone acetate is C 24H 31FO 6and it has a molecular weight of 434.50. Chemically, it is 9-Fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 21-acetate.

The chemical structures for betamethasone sodium phosphate and betamethasone acetate are as follows:

betamethasone sodium phosphate

betamethasone acetate

Betamethasone sodium phosphate is a white to practically white, odorless powder, and is hygroscopic. It is freely soluble in water and in methanol, but is practically insoluble in acetone and in chloroform.

Betamethasone acetate is a white to creamy white, odorless powder that sinters and resolidifies at about 165ºC, and remelts at about 200ºC to 220ºC with decomposition. It is practically insoluble in water, but freely soluble in acetone, and is soluble in alcohol and in chloroform.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Betaloan SUIK - FDA Drug Approval Details